Comparative study for mucosal concentration of 5-ASA by once-daily vs divided dosing of oral mesalazine in quiescent ulcerative colitis
Not Applicable
- Conditions
- ulcerative colitis
- Registration Number
- JPRN-UMIN000010127
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Kyoto University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with severe active or fulminant ulcerative colitis 2) Patients who received total or subtotal colectomy 3) Patients with malignancy 4) Patients who are pregnant or have the possibility of pregnancy 5) Patients whom investigators and subinvestigators considered to be inappropriate to participate in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mucosal concentration of 5-ASA in the Rectum
- Secondary Outcome Measures
Name Time Method Mucosal concentration of Ac-5-ASA in the rectum